Cannabis as a substitute for alcohol and other drugs: A dispensary-based survey of substitution effect in Canadian medical cannabis patients

References

• Aharonovich, E., Garawi, F., Bisaga, A., Brooks, D., Raby, W.N., Rubin, E., … Australian Institute of Health and Welfare (2002) 2001 National Drug Strategy Household Survey: First results. AIHW cat. no. PHE 35. Canberra: AIHW (Drug Statistics Series No. 9). Retrieved from http://www.aihw.gov.au/publication-detail/?id=6442467340
   Google Scholar
• Balerio G, Aso NE, Maldonado R. Role of the cannabinoid system in the effects induced by nicotine on anxiety-like behaviour in mice. Psychopharmacology 2006; 184: 504–513
   PubMed Web of Science ®Google Scholar
• Belle-Isle, L. (2006). Cannabis as therapy for people living with HIV/AIDS; Our Right, Our Choice. Canadian AIDS Society. Retrieved from http://www.cdnaids.ca/files.nsf/pages/cannabis_english/$file/cannabis_english.pdf
   Google Scholar
• Blume, L., Bass, C., Childers, S., Dalton, G., Richardson, J., Selley, D., … Howlett, A. (2011). Cannabinoid receptor interacting protein 1A (CRIP1A) modulates striatal neuropharmacology and signal transduction in cannabinoid, dopamine and opioid receptor systems (2011). 21st Annual Symposium on the Cannabinoids (pp. 2–21). Research Triangle Park, NC: International Cannabinoid Research Society.
   Google Scholar
• Damaj, M., & Lichtman, A. (2011) Nicotine reward: A role for CB2 receptors? 21st Annual Symposium on the Cannabinoids (p. 45). Research Triangle Park, NC: International Cannabinoid Research Society.
   Google Scholar
• Devkota, S., & Mukhopadhyay, S. (2011) Cannabinoid-ethanol interaction in the regulation of developing neurogenesis in zebrafish brain. 21st Annual Symposium on the Cannabinoids (pp. 3–8). Research Triangle Park, NC: International Cannabinoid Research Society.
   Google Scholar
• Dhalla I, Mamdani M, Sivilotti M. Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone. CMAJ 2009; 181: 891–896
   PubMed Web of Science ®Google Scholar
• Earleywine M, Smucker Barnwell S. Decreased respiratory symptoms in cannabis users who vaporize. Harm Reduction Journal 2007; 4: 11
   PubMedGoogle Scholar
• Fischer B, Rehm J, Goldman B, Popova S. Non-medical use of prescription opioids and public health in Canada: An urgent call for research and intervention development. Canadian Jounal on Public Health 2008; 99: 182–184
   PubMed Web of Science ®Google Scholar
• Gieringer, D. (2006). 10th Anniversary of Prop. 215; California Leads, Feds Still Lag on Medical Marijuana. Oakland, CA. Retrieved from California NORML website: http://canorml.org/news/10thAnniversaryProp215.htm
   Google Scholar
• Grinspoon L. Medical marijuana in a time of prohibition. International Journal of Drug Policy 1999; 10: 145–156
   Google Scholar
• Grinspoon L, Bakalar JB. Marijuana the forbidden medicine. Yale University Press, New Haven, CT 1993
   Google Scholar
• Howard, J., Banks, S., Golinski, M., & Stinchcomb, A. (2011). Development of cannabidiol prodrugs for use with microneedles for the treatment of alcohol use disorders. 21st Annual Symposium on the Cannabinoids (pp. 3–18). Research Triangle Park, NC: International Cannabinoid Research Society.
   Google Scholar
• Hursh SR, Galuska CM, Winger G, Woods JH. The economics of drug abuse: A quantitative assessment of drug demand. Molecular Interventions 2005; 5: 20–28
   PubMed Web of Science ®Google Scholar
• Labigalini Jr E, Rodrigues LR, Da Silveira DX. Therapeutic use of cannabis by crack addicts in Brazil. Journal of Psychoactive Drugs 1999; 31: 451–455
   PubMed Web of Science ®Google Scholar
• Levin FR. Concurrent cannabis use during treatment for comorbid ADHD and cocaine dependence: Effects on outcome. American Journal of Drug and Alcohol Abuse 2006; 32: 629–635
   PubMedGoogle Scholar
• Liput, D., Pendergast, M., & Nixon, K. (2011). Endocannabinoid modulation attenuates ethanol-induced neurodegeneration during withdrawal. 21st Annual Symposium on the Cannabinoids (p. 32). Research Triangle Park, NC: International Cannabinoid Research Society.
   Google Scholar
• Lopez-Quintero C, Hasin DS, de Los Cobos JP, Pines A, Wang S, Grant BF, Blanco C. Probability and predictors of remission from life-time nicotine, alcohol, cannabis or cocaine dependence: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Addiction 2011; 106: 657–669
   PubMed Web of Science ®Google Scholar
• Los Angeles Times (2009). No quick action seen on L.A. marijuana dispensaries. Retrieved from http://www.latimes.com/news/local/la-me-medical-marijuana4-2009nov04,0,4490002.story
   Google Scholar
• Lucas, R.V. (2002). Victoria Registry No. 113701C, (Prov. Ct. B.C; July 5, 2002).
   Google Scholar
• Lucas P. Regulating compassion; an overview of Health Canada's medical cannabis policy and practice. Harm Reduction Journal 2008; 5: 5
   PubMed Web of Science ®Google Scholar
• Lucas P. Moral regulation and the presumption of guilt in Health Canada's medical cannabis policy and practice. International Journal of Drug Policy 2009; 20: 296–303
   PubMed Web of Science ®Google Scholar
• Lucas P. It can’t hurt to ask; a patient-centered quality of service assessment of Health Canada's medical cannabis policy and program. Harm Reduction Journal 2012; 9: 2
   PubMedGoogle Scholar
• Maitra, R., Bortoff, K., Pan, H., Reggio, P., & Seltzman, H. (2011). Inhibition of alcoholic hepatic steatosis by a Type 1 Cannabinoid receptor neutral antagonist. 21st Annual Symposium on the Cannabinoids (p. 23). Research Triangle Park, NC: International Cannabinoid Research Society.
   Google Scholar
• Mikuriya T. Cannabis as a substitute for alcohol: A harm reduction approach. Journal of Cannabis Therapeutics 2004; 4: 79–93
   Google Scholar
• Model KE. The effect of marijuana decriminalization on hospital emergency drug episodes: 1975–1978. Journal of the American Statistical Association 1993; 88: 737–747
   Web of Science ®Google Scholar
• Moore TJ, Cohen MR, Furberg CD. Serious adverse drug events reported to the Food and Drug Administration, 1998–2005. Archives of Internal Medicine 2007; 167: 1752–1759
   PubMed Web of Science ®Google Scholar
• Muldoon, P., Lichtman, A., & Damaj, I. (2011). The role of 2-AG endocannabinoid neurotransmission in nicotine reward and withdrawal (2011). 21st Annual Symposium on the Cannabinoids (pp. 3–24). Research Triangle Park, NC: International Cannabinoid Research Society.
   Google Scholar
• Nunberg H, Kilmer B, Pacula R, Burgdorf J. An analysis of applicants presenting to a medical marijuana specialty practice in California. Journal of Drug Policy Analysis 2011; 4: 1
   PubMedGoogle Scholar
• Perkonigg A, Goodwin RD, Fiedler A, Behrendt S, Beesdo K, Lieb R, Wittchen HU. The natural course of cannabis use, abuse and dependence during the first decades of life. Addiction 2008; 103: 439–449
   PubMed Web of Science ®Google Scholar
• Ramesh, D., Owens, R., Kinsey, S., Cravatt, B., Sim-Selley, L., & Lichtman, A. (2011). Effects of chronic manipulation of the endocannabinoid system on precipitated opioid withdrawal. 21st Annual Symposium on the Cannabinoids (pp. 3–22). Research Triangle Park, NC: International Cannabinoid Research Society.
   Google Scholar
• Reiman, A. (2006). Cannabis care: Medical cannabis facilities as health service providers (Dissertation). School of Social Welfare/Alcohol Research Group, University of California, Berkeley.
   Google Scholar
• Reiman A. Cannabis as a substitute for alcohol and other drugs. Harm Reduction Journal 2009; 6: 35
   PubMed Web of Science ®Google Scholar
• Schwartz R. Medical marijuana users in substance abuse treatment. Harm Reduction Journal 2010; 7: 3
   PubMedGoogle Scholar
• Statistics Canada (2012). Individuals by total income level, by province and territory. Retrieved from http://www.statcan.gc.ca/tables-tableaux/sum- som/l01/cst01/famil105a-eng.htm
   Google Scholar
• Substance Abuse and Mental Health Services Administration, (2007). Results from the 2006 National Survey on Drug Use and Health: National Findings (NSDUH Series H-32, DHHS Publication No. SMA 07-4293). Rockville, MD: Office of Applied Studies.
   Google Scholar
• United Nations Office for Drug Control and Crime Prevention (2001). World drug report 2001 (pp. 30–32). Oxford: Oxford University Press.
   Google Scholar